/
/
/

Orchid Pharma Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Dec 2011Dec 2010Dec 2009Dec 2008Jun 2008Jun 2007Jun 2006
₹304 Cr₹238 Cr₹207 Cr₹194 Cr₹263 Cr₹237 Cr₹217 Cr₹223 Cr₹244 Cr₹217 Cr₹221 Cr₹199 Cr₹183 Cr₹210 Cr₹160 Cr₹165 Cr₹131 Cr₹178 Cr₹161 Cr₹128 Cr₹92 Cr₹120 Cr₹103 Cr₹109 Cr₹119 Cr₹112 Cr₹129 Cr₹132 Cr₹135 Cr₹497 Cr₹479 Cr₹360 Cr₹336 Cr₹310 Cr₹252 Cr₹213 Cr
₹2 Cr₹7 Cr₹6 Cr₹11 Cr₹12 Cr₹4 Cr₹8 Cr₹8 Cr₹8 Cr₹13 Cr₹8 Cr₹8 Cr₹2 Cr₹2 Cr₹9 Cr₹6 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹11 Cr₹2 Cr₹93 L₹1 Cr₹6 Cr₹7 Cr₹7 Cr₹5 Cr₹0₹3 L₹0₹1 L₹18 Cr₹53 Cr₹75 L
₹306 Cr₹245 Cr₹213 Cr₹204 Cr₹275 Cr₹241 Cr₹226 Cr₹230 Cr₹252 Cr₹230 Cr₹228 Cr₹207 Cr₹185 Cr₹212 Cr₹169 Cr₹171 Cr₹134 Cr₹180 Cr₹164 Cr₹130 Cr₹95 Cr₹131 Cr₹105 Cr₹109 Cr₹120 Cr₹117 Cr₹136 Cr₹138 Cr₹141 Cr₹497 Cr₹479 Cr₹360 Cr₹336 Cr₹328 Cr₹305 Cr₹213 Cr
₹301 Cr₹220 Cr₹215 Cr₹204 Cr₹279 Cr₹218 Cr₹200 Cr₹201 Cr₹220 Cr₹197 Cr₹194 Cr₹183 Cr₹168 Cr₹177 Cr₹154 Cr₹165 Cr₹140 Cr₹179 Cr₹168 Cr₹137 Cr₹113 Cr₹122 Cr₹137 Cr₹121 Cr₹130 Cr₹155 Cr₹161 Cr₹164 Cr₹179 Cr₹406 Cr₹380 Cr₹328 Cr₹268 Cr₹273 Cr₹215 Cr₹177 Cr
₹16 Cr₹34 Cr₹7 Cr₹9 Cr₹6 Cr₹32 Cr₹35 Cr₹38 Cr₹40 Cr₹42 Cr₹43 Cr₹32 Cr₹24 Cr₹41 Cr₹23 Cr₹24 Cr₹15 Cr₹28 Cr₹16 Cr₹13 Cr₹3 Cr₹29 Cr-₹3 Cr₹19 Cr₹21 Cr-₹7 Cr₹7 Cr₹6 Cr-₹7 Cr₹129 Cr₹131 Cr₹72 Cr₹101 Cr₹87 Cr₹114 Cr₹56 Cr
₹2 Cr₹3 Cr₹3 Cr₹4 Cr₹2 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr₹4 Cr₹6 Cr₹7 Cr₹8 Cr₹9 Cr₹8 Cr₹4 Cr₹7 Cr₹10 Cr₹11 Cr₹12 Cr₹13 Cr₹13 Cr₹14 Cr₹78 L₹3 Cr₹9 L₹0₹50 Cr₹27 Cr₹54 Cr₹38 Cr₹30 Cr₹17 Cr₹22 Cr
₹3 Cr₹23 Cr-₹12 Cr-₹3 Cr-₹7 Cr₹19 Cr₹22 Cr₹26 Cr₹28 Cr₹30 Cr₹30 Cr₹20 Cr₹11 Cr₹66 Cr₹7 Cr-₹3 Cr-₹14 Cr-₹4 Cr-₹11 Cr-₹17 Cr-₹28 Cr-₹3 Cr-₹45 Cr-₹24 Cr-₹23 Cr-₹39 Cr-₹28 Cr-₹26 Cr-₹38 Cr-₹8 Cr₹76 Cr-₹17 Cr-₹1 Cr-₹34 Cr₹73 Cr₹14 Cr
₹3 Cr₹23 Cr-₹12 Cr-₹3 Cr-₹7 Cr₹19 Cr₹22 Cr₹26 Cr₹28 Cr₹34 Cr₹30 Cr₹20 Cr₹11 Cr₹59 Cr₹7 Cr-₹3 Cr-₹14 Cr-₹5 Cr-₹14 Cr₹49 Cr-₹31 Cr-₹25 Cr-₹45 Cr-₹24 Cr-₹23 Cr-₹39 Cr-₹28 Cr-₹26 Cr-₹38 Cr-₹11 Cr₹57 Cr-₹19 Cr-₹5 Cr-₹34 Cr₹49 Cr₹11 Cr

Share Price Live Stats

Open (₹)945.25
Volume (₹)42,563.00
High (₹)950.25
Upper Circuit1,134.30
Low (₹)925.00
Lower Circuit756.20
Prev Close945.25
52W High (₹)1,143.50
Price928.05
52W Low (₹)480.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)5673.82 Cr
Div. Yield (%)0.00
PE Ratio654.72
Debt to Equity0.20
Price to Book0.48
Book Value993.34
EPS (TTM)1.45
Face Value10.00
ROE (%)0.70

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
ORCHPHARMANSE
LTP
1W Low
1W High
Market cap (₹)
1764+4 (0.23%)
1725.50
1778
4,19,620Cr
9030-310 (-3.32%)
8937.50
9431.50
2,39,714Cr
4584.1-72.8 (-1.56%)
4551.80
4682
1,74,741Cr
1140.2+22.7 (2.03%)
1107.30
1150.90
1,12,119Cr
2018.5-18.1 (-0.89%)
2007.80
2069.20
1,10,008Cr
1328+27 (2.08%)
1300.20
1336.40
1,06,061Cr
1218.8+21.8 (1.82%)
1196.90
1250.70
1,01,339Cr
2347.6-20.9 (-0.88%)
2317.50
2426.80
96,244Cr
1677.9-15.1 (-0.89%)
1647.10
1715
95,590Cr
1980.9+24.4 (1.25%)
1925.70
1990.90
89,391Cr
928.05-55.9 (-5.68%)
925
998.75
5,674Cr

Key Highlights of Orchid Pharma Ltd’s P&L

In 2025-03-31, Orchid Pharma Ltd reported total revenue of ₹956.37Cr, compared with ₹850.5Cr in 2024-03-31, reflecting Orchid Pharma Ltd turnover.

Depreciation was ₹34.55Cr and finance costs were ₹14.93Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹95.56Cr in 2025-03-31 as compared to ₹91.95Cr in 2024-03-31.

Net Profit (PAT) was ₹99.66Cr in 2025-03-31 compared with ₹92.17Cr in 2024-03-31.

Earnings per share (EPS) were ₹19.65 in 2025-03-31, compared with ₹18.17 in 2024-03-31.